12 Health Care Stocks Moving In Monday's Pre-Market Session

BenzingaDec 9 16:05 ET

Express News | Sonnet BioTherapeutics Announces $3.9M Registered Direct Offering And Concurrent Private Placement, Selling 1.76M Shares And Warrants Priced At-The-Market Under Nasdaq Rules With $2.23 Combined Price And $2.10 Warrant Exercise Price

BenzingaDec 9 15:43 ET

Sonnet BioTherapeutics Announces $3.9 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market Under Nasdaq Rules

GlobeNewswireDec 9 15:42 ET

Sector Update: Health Care Stocks Edge Higher Monday Afternoon

MT NewswiresDec 9 13:48 ET

Sector Update: Health Care

MT NewswiresDec 9 13:30 ET

Sonnet BioTherapeutics Shares Are Trading Higher After the Company Announced the Highest Dose of Its Phase 1 SB101 Trial Results for SON-1010 Have Been Formally Evaluated by the Safety Review Committee, With the Maximum Tolerated Dose Set at 1200ng/kg.

BenzingaDec 9 10:57 ET